Table 1: Baseline characteristics of the patient
population.
|
Parameter |
Classification |
Number |
% |
|
Age |
<50 |
17 |
15.6% |
|
50-59 |
32 |
29.4% |
|
|
60-69 |
33 |
30.3% |
|
|
70+ |
27 |
24.8% |
|
|
Race |
African American |
10 |
9.2% |
|
Caucasian |
99 |
90.8% |
|
|
Sex |
Female |
19 |
17.4% |
|
Male |
90 |
82.6% |
|
|
Tobacco use >10 pack years |
Yes |
69 |
63.3% |
|
No |
40 |
36.7% |
|
|
Primary Tumor |
Oral Cavity |
4 |
3.7% |
|
Oropharynx |
68 |
62.4% |
|
|
Hypopharynx |
7 |
6.4% |
|
|
Larynx |
30 |
27.5% |
|
|
T-Stage |
T1 |
16 |
14.7% |
|
T2 |
48 |
44.0% |
|
|
T3 |
27 |
24.8% |
|
|
T4 |
2 |
1.8% |
|
|
T4a |
12 |
11.0% |
|
|
T4b |
4 |
3.7% |
|
|
N-Stage |
N0 |
18 |
16.5% |
|
N1 |
15 |
13.8% |
|
|
N2a |
13 |
11.9% |
|
|
N2b |
38 |
34.9% |
|
|
N2c |
17 |
15.6% |
|
|
N3 |
8 |
7.3% |
|
|
Clinical Stage |
II |
6 |
5.5% |
|
III |
22 |
20.2% |
|
|
IVA |
70 |
64.2% |
|
|
IVB |
11 |
10.1% |